vorasidenib
servier
['vorasidenib', 'indigo', 'thanks']
dr. mellinghoff presenting results of indigo, vorasidenib vs placebo for recurrent/residual idh1/2 mutated who grade ii gliomas. pfs 27.7 vs 11.1 (hr 0.39). grateful for advances in a difficult field, one special to me thanks to time working at btc! #asco23 
Medical oncologist: GI cancers & cancer of unknown primary + high quality & value-based cancer care delivery. @UTexasValue MSHCT student. Tweets mine.